Recently, treatment with the steroidal lactone withaferin A was found to induce the nuclear factor erythroid 2–related factor 2 (Nrf2) pathway and to inactivate the GPx4 pathway, a duality making this strategy highly effective in treating both neuroblastoma cells and transplanted xenografts in mice (16). The gene discussed is GPX4; the disease is neuroblastoma.